# Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects

> **NCT00953888** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 203 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD5069
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00953888
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2015-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00953888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00953888, "Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00953888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*